Real-time enrollment status for this metastatic urothelial carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 11:02 AM UTC
| NCT Number | NCT07221942 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Urothelial Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 97 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fox Chase Cancer Center |
| Last Updated on CT.gov | February 19, 2026 (Feb 19, 2026) |
As of July 13, 2026: Clinical trial NCT07221942 is currently recruiting participants. This clinical trial study for metastatic urothelial carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Fox Chase Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07221942 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07221942 was last updated Feb 19, 2026 (February 19, 2026). HelloStudys verifies this status automatically.